EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Wharton's Jelly mesenchymal stem cell‐derived extracellular vesicles induce liver fibrosis‐resolving phenotype in alternatively activated macrophages

Shukoofeh Torabi, Morteza Zarrabi, Faezeh Shekari, Hedie Poorkazem, Majid Lotfinia, Stefan Bencina, Roberto Gramignoli, Moustapha Hassan, Mustapha Najimi iD, Massoud Vosough

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.18507 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Shukoofeh Torabi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Liver Cirrhosis, Extracellular Vesicles, Macrophages. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bahar Tashkhis Teb Co, Royan Institute, Åke Wiberg Stiftelse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The potential of extracellular vesicles (EVs) isolated from mesenchymal stromal cells in guiding macrophages toward anti‐inflammatory immunophenotypes, has been reported in several studies. In our study, we provided experimental evidence of a distinctive effect played by Wharton Jelly mesenchymal stromal cell‐derived EVs (WJ‐EVs) on human macrophages. We particularly analyzed their anti‐inflammatory effects on macrophages by evaluating their interactions with stellate cells, and their protective role in liver fibrosis. A three‐step gradient method was used to isolate monocytes from umbilical cord blood (UCB). Two subpopulations of WJ‐EVs were isolated by high‐speed (20,000 g ) and differential ultracentrifugation (110,000 g ). Further to their characterization, they were designated as EV20K and EV110K and incubated at different concentrations with UCB‐derived monocytes for 7 days. Their anti‐fibrotic effect was assessed by studying the differentiation and functional levels of generated macrophages and their potential to modulate the survival and activity of LX2 stellate cells. The EV20K triggers the polarization of UCB‐derived monocytes towards a peculiar M2‐like functional phenotype more effectively than the M‐CSF positive control. The EV20K treated macrophages were characterized by a higher expression of scavenger receptors, increased phagocytic capacity and production level of interleukin‐10 and transforming growth factor‐β. Conditioned medium from those polarized macrophages attenuated the proliferation, contractility and activation of LX2 stellate cells. Our data show that EV20K derived from WJ‐MSCs induces activated macrophages to suppress immune responses and potentially play a protective role in the pathogenesis of liver fibrosis by directly inhibiting HSC’s activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsLiver CirrhosisExtracellular VesiclesMacrophagesWharton JellyPhenotypeCell DifferentiationHumansMacrophage ActivationHepatic Stellate CellsMonocytesPhagocytosisFetal Blood

Stichwörter der Autor:innen

Wharton's jelly mesenchymal stem cellanti‐inflammatory macrophagesextracellular vesiclesliver fibrosis

Autor:innen und Institutionen

  • Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
  • Department of Tissue Engineering and Regenerative Medicine, School of Advanced Technologies in Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
  • Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
  • Physiology Research Center, Kashan University of Medical Sciences, Kashan, Iran.
  • Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Stockholm, Sweden.
  • UOSD Cell Factory, IRCCS Istituto Giannina Gaslini, Genoa, Italy.

ORCID-Profile: Mustapha Najimi

Förderung

  • Bahar Tashkhis Teb Co
  • Royan Institute
  • Åke Wiberg Stiftelse
  • Royan Stem Cell Technology

Zitieren

APA

Torabi, S., Zarrabi, M., Shekari, F., Poorkazem, H., Lotfinia, M., Bencina, S., Gramignoli, R., Hassan, M., Najimi, M., & Vosough, M. (2024). Wharton's Jelly mesenchymal stem cell‐derived extracellular vesicles induce liver fibrosis‐resolving phenotype in alternatively activated macrophages. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18507

Vancouver

Torabi S, Zarrabi M, Shekari F, Poorkazem H, Lotfinia M, Bencina S, et al. Wharton's Jelly mesenchymal stem cell‐derived extracellular vesicles induce liver fibrosis‐resolving phenotype in alternatively activated macrophages. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18507

BibTeX
@article{Torabi2024,
  author = {Torabi, Shukoofeh and Zarrabi, Morteza and Shekari, Faezeh and Poorkazem, Hedie and Lotfinia, Majid and Bencina, Stefan and Gramignoli, Roberto and Hassan, Moustapha and Najimi, Mustapha and Vosough, Massoud},
  title = {Wharton's Jelly mesenchymal stem cell‐derived extracellular vesicles induce liver fibrosis‐resolving phenotype in alternatively activated macrophages},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.18507}
}
Kostenlos starten →